Work

Phase I Trial of the Base – Excision Repair Blocker Methoxyamine (TRC-102) Combined with Fludarabine in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Lymphoid Malignancies

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.4688.4688

Authors: Paolo Caimi, Brenda Cooper, Basem M. William, Erica L Campagnaro, Richard J. Creger, Manuel Afable, Yan Xu, John Pink, Afshin Dowlati, Hillard M. Lazarus, Marcos de Lima, Stanton L. Gerson

Institutions: University Hospitals of Cleveland, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland State University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2551529658

FWCI: 0.151

Cites:

Cited by: 3

Related to: 10